Why is Remedium Life falling/rising?

As of 24-Sep, Remedium Lifecare Ltd's stock price is currently at 1.50, showing no change (0.00%). The stock's performance today is inline with the sector, and it is trading higher than its 20-day, 50-day, and 100-day moving averages, but lower than its 5-day and 200-day moving averages. The stock has seen a delivery volume of 1.43 crore on 23 September, which is a 25.35% increase compared to the 5-day average, indicating rising investor participation. However, the company has a high Debt to EBITDA ratio of -1.00 times and has reported losses over the last four consecutive quarters, contributing to a negative return on capital employed (ROCE) and poor long-term growth. The stock has underperformed significantly over the past year, with a return of -76.28%, compared to the benchmark's negative return of -5.32%.
In the broader market context, while the Sensex has shown a slight gain of 0.50% over the past month, Remedium Lifecare Ltd has outperformed with a return of +12.78% in the same period. However, the stock's year-to-date performance is concerning, with a decline of -58.03%, indicating a significant struggle compared to the benchmark's gain of +4.58%. The company's negative financial results, including a drastic fall in net sales and operating profit, along with a negative EBITDA, suggest that despite some short-term gains, the overall outlook remains bleak, contributing to the stock's volatility and riskiness in the market.